People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Myoscience, Inc | — | Other | Series B | $122.6M | $83.1M | 2011 |
Robert M. Grant at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert M. Grant on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Ferrari | 1 | 15 |
| Robert Grant | 1 | 12 |
| Anthony Lando | 1 | 6 |
| Brian Farley | 1 | 5 |
| Richard M. Ferrari | 1 | 5 |
| Clint Carnell | 1 | 4 |
| Cary . Vance | 1 | 4 |
| Rudi Marien | 1 | 3 |
| Thomas E. Hancock | 1 | 3 |
| Jon Serbousek | 1 | 3 |
| Thomas Weldon | 1 | 3 |
| Jan Pensaert | 1 | 3 |
| Bernard Coulie | 1 | 2 |
| Jeffrey M. Nugent | 1 | 2 |
| Joe Whitters | 1 | 2 |
| Robert M. Curtis | 1 | 2 |
| John Allison | 1 | 2 |
| Thomas D. Weldon | 1 | 2 |
| Jeffrey Nugent | 1 | 1 |
| Thomas M. Weldon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.